Skip to main content

Articles

Page 89 of 107

  1. Women who have undergone a full-term pregnancy before the age of 20 have one-half the risk of developing breast cancer compared with women who have never gone through a full-term pregnancy. This protective eff...

    Authors: Lakshmanaswamy Rajkumar, Raphael C Guzman, Jason Yang, Gudmundur Thordarson, Frank Talamantes and Satyabrata Nandi
    Citation: Breast Cancer Research 2003 6:R31
  2. Many laboratories are currently evaluating the usefulness of determination of HER2, p53, and Ki67 proliferation indices using immunohistochemical techniques in cancer. Although the available studies suggest th...

    Authors: Hiroko Yamashita, Mariko Nishio, Tatsuya Toyama, Hiroshi Sugiura, Zhenhuan Zhang, Shunzo Kobayashi and Hirotaka Iwase
    Citation: Breast Cancer Research 2003 6:R24
  3. The androgen-regulated proteins prostate-specific antigen (PSA) and prostate-specific acid phosphatase (PSAP) are present in high concentrations in normal prostate and prostatic cancer and are considered to be...

    Authors: Noman Kidwai, Yun Gong, Xiaoping Sun, Charuhas G Deshpande, Anjana V Yeldandi, M Sambasiva Rao and Sunil Badve
    Citation: Breast Cancer Research 2003 6:R18
  4. Metastasis in breast cancer significantly increases morbidity and mortality. The 5-year survival rate reduces from 90% for localised disease to about 20% once metastasis has taken place. The phosphoinositide 3...

    Authors: Noan-Minh Chau and Margaret Ashcroft
    Citation: Breast Cancer Research 2003 6:55
  5. Rodent models for breast cancer have for many decades provided unparalleled insights into cellular and molecular aspects of neoplastic transformation and tumorigenesis. Despite recent improvements in the fidel...

    Authors: Kay-Uwe Wagner
    Citation: Breast Cancer Research 2003 6:31
  6. The four-day biennial 8th Nottingham Breast Cancer Conference held at the East Midlands Conference Centre, University of Nottingham, UK (16–19 September 2003) once again proved to be a successful event. Recent...

    Authors: Jane L Limer, Alicia T Parkes, Alison Waterworth, Claire E Murphy, Cathy R Tait and Caroline J Witton
    Citation: Breast Cancer Research 2003 6:E1
  7. The prognostic significance of germline mutations in BRCA1 and BRCA2 in women with breast cancer remains unclear. A combined analysis was performed to address this uncertainty.

    Authors: Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit and William D Foulkes
    Citation: Breast Cancer Research 2003 6:R8
  8. The presence and distribution of interleukin-2 (IL-2) and its receptor complex (Rα, Rβ, Rγ) were studied in 52 women who were clinically and histopathologically diagnosed with breast tumours (17 in situ and 35 in...

    Authors: Ignacio García-Tuñón, Mónica Ricote, Antonio Ruiz, Benito Fraile, Ricardo Paniagua and Mar Royuela
    Citation: Breast Cancer Research 2003 6:R1
  9. Array-based comparative genomic hybridization, RNA expression profiling, and proteomic analyses are new molecular technologies used to study breast cancer. Invasive breast cancers were originally evaluated bec...

    Authors: Stefanie S Jeffrey and Jonathan R Pollack
    Citation: Breast Cancer Research 2003 5:320
  10. Estrogen is a mitogenic factor that is implicated in the genesis and progression of breast cancer via its binding to estrogen receptor (ER)-α. Synthesis of estrogen in situ is believed to be catalyzed mainly by a...

    Authors: Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Yoko Omoto, Hiroshi Sugiura, Yasuo Hara, Xueqing Wu, Shunzo Kobayashi and Hirotaka Iwase
    Citation: Breast Cancer Research 2003 5:R250
  11. HER-2 (c-erbB2/Neu) predicts the prognosis of and may influence treatment responses in breast cancer. HER-2 activity induces the cytoplasmic location of p21WAFI/CIPI in cell culture, accompanied by resistance to ...

    Authors: Zoë E Winters, Russell D Leek, Mike J Bradburn, Chris J Norbury and Adrian L Harris
    Citation: Breast Cancer Research 2003 5:R242
  12. Our previous studies detected focal disruptions in myoepithelial cell layers of several ducts with carcinoma in situ. The cell cluster overlying each of the myoepithelial disruptions showed a marked reduction in ...

    Authors: Yan-gao Man, Lisa Tai, Ross Barner, Russell Vang, Jeffrey S Saenger, Kris M Shekitka, Gary L Bratthauer, Darren T Wheeler, Chang Y Liang, Tuyethoa N Vinh and Brian L Strauss
    Citation: Breast Cancer Research 2003 5:R231

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions